Skip to main content
. 2016 Jan 8;6:18826. doi: 10.1038/srep18826

Figure 2. Overview of global MS-based drug profiling using five subcellular fractions and complete regulative functional analysis.

Figure 2

The strategy constitutes a novel MS-based drug profiling and data analysis workflow.